Sofosbuvir and Ledipasvir Tablet Exporter India, Manufacturer and Global Supplier

Sofosbuvir and Ledipasvir Tablet is a highly effective combination antiviral therapy used for the treatment of chronic hepatitis C virus (HCV) infection. As a leading Sofosbuvir and Ledipasvir Tablet Exporter India, we supply premium-quality formulations manufactured under WHO-GMP and ISO-certified facilities. Our products are globally trusted for safety, efficacy, and compliance with international pharmaceutical standards, making us a reliable supplier for hospitals, distributors, and healthcare institutions worldwide.

Sofosbuvir is a direct-acting antiviral (DAA) that inhibits HCV RNA polymerase, while Ledipasvir is an NS5A inhibitor that blocks viral replication. The combination therapy is highly effective against HCV genotypes 1, 4, 5, and 6, providing a potent antiviral effect with minimal side effects. It is widely prescribed for patients with or without compensated liver disease, helping achieve sustained virologic response (SVR) in most cases.

As a reputed Sofosbuvir and Ledipasvir Tablet Exporter India, we ensure each batch undergoes stringent quality control testing and secure packaging to maintain stability during storage and international shipping.

Key Uses of Sofosbuvir and Ledipasvir Tablet

• Treatment of chronic hepatitis C infection

• Effective against HCV genotypes 1, 4, 5, and 6

• Reduces viral load and prevents progression to liver cirrhosis or hepatocellular carcinoma

• Used in combination therapy for patients with advanced liver disease or treatment-experienced patients

• Helps achieve high cure rates with sustained virologic response (SVR)

• Suitable for patients with or without compensated liver disease

Precautions to Follow

Patients should use Sofosbuvir and Ledipasvir Tablets strictly under medical supervision. Important precautions include:

• Take the tablet exactly as prescribed, usually once daily with or without food

• Inform your doctor of any liver or kidney conditions before starting therapy

• Avoid alcohol during treatment to minimize liver stress

• Not recommended during pregnancy or breastfeeding unless clearly advised by a healthcare provider

• Complete the full course of therapy to ensure maximum efficacy

• Regular monitoring of liver function tests is recommended during treatment

As a responsible Sofosbuvir and Ledipasvir Tablet Exporter India, we provide complete product documentation, safety guidelines, and regulatory support for global clients.

Possible Side Effects

Sofosbuvir and Ledipasvir Tablet is generally well-tolerated, but some patients may experience mild side effects such as:

• Fatigue or weakness

• Headache

• Nausea or vomiting

• Insomnia or dizziness

• Mild anemia when used in combination with other DAAs

Serious adverse effects are rare but should be reported immediately to a healthcare professional.

Why Choose Us as Your Sofosbuvir and Ledipasvir Tablet Exporter India?

• WHO-GMP and ISO-certified manufacturing facilities

• High-quality formulations with strict quality control

• Compliance with international pharmacopeia standards (IP/BP/USP)

• Customized packaging and labeling options to meet client requirements

• Competitive pricing with assured timely delivery

• Strong global presence in Asia, Africa, Middle East, and Latin America

We are a trusted Sofosbuvir and Ledipasvir Tablet Exporter India, supplying reliable pharmaceutical solutions to hospitals, distributors, NGOs, and government tenders worldwide.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.